Retrophin Inc (RTRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RTRX | LGND | TARS | ||
| Company | Retrophin Inc | Ligand Pharm | Tarsus Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.57 | 71.77 | 32.31 | ||
| High | 24.74 | 72.70 | 33.34 | ||
| Low | 24.04 | 70.86 | 32.02 | ||
| Last | 24.25 | 71.81 | 32.72 | ||
| Change | -0.11 | +0.39 | +0.23 | ||
| % Change | -0.45% | +0.55% | +0.71% | ||
| Volume | 378,900 | 5,715 | 27,982 | ||
| 20-Day Average Volume | 335,225 | 144,511 | 501,293 | ||
| Previous Close | 24.36 | 71.42 | 32.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 22.07 | 74.99 | 33.87 | ||
| 20-Day Raw Stochastic | 86.95% | 26.91% | 25.44% | ||
| 20-Day Relative Strength | 67.64% | 45.55% | 47.45% | ||
| Weighted Alpha | +75.80 | -4.26 | +121.74 | ||
| Today's Opinion | 100% Buy | 40% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 40% Buy | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.04% since 11/11/20 | +1.59% since 04/25/24 | +0.34% since 04/25/24 | ||
| Low | 23.33 on 11/13/20 | 69.51 on 05/01/24 | 30.23 on 04/30/24 | ||
| High | 24.74 on 11/18/20 | 72.70 on 05/02/24 | 33.49 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | +10.78% since 10/16/20 | -2.35% since 04/02/24 | -9.16% since 04/02/24 | ||
| Low | 19.52 on 11/02/20 | 67.72 on 04/22/24 | 30.23 on 04/30/24 | ||
| High | 24.96 on 11/11/20 | 81.73 on 04/12/24 | 38.46 on 04/11/24 | ||
| 3-Month | |||||
| %Chg | +31.58% since 08/18/20 | -4.09% since 02/02/24 | +13.24% since 02/02/24 | ||
| Low | 17.22 on 09/24/20 | 67.72 on 04/22/24 | 27.44 on 02/05/24 | ||
| High | 24.96 on 11/11/20 | 94.57 on 02/27/24 | 40.40 on 02/28/24 | ||
| 6-Month | |||||
| %Chg | +47.33% since 05/18/20 | +37.98% since 11/02/23 | +120.61% since 11/02/23 | ||
| Low | 14.50 on 06/11/20 | 51.21 on 11/09/23 | 14.93 on 11/03/23 | ||
| High | 24.96 on 11/11/20 | 94.57 on 02/27/24 | 40.40 on 02/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,238,011 | 1,264,490 | 1,227,375 | ||
| Shares Outstanding, K | 51,052 | 17,705 | 37,777 | ||
| Annual Sales | 175,340,000 | 131,310,000 | 17,450,000 | ||
| Annual Net Income | -146,430,000 | 52,150,000 | -135,890,000 | ||
| Last Quarter Sales | 51,140,000 | 28,100,000 | 13,080,000 | ||
| Last Quarter Net Income | -22,550,000 | 18,190,000 | -41,900,000 | ||
| 60-Month Beta | 0.71 | 1.01 | 1.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 02/24/20 | 1.05 on 02/27/24 | -1.31 on 02/27/24 | ||
| Latest Earnings Date | 11/05/20 | 05/07/24 | 05/14/24 | ||
| Most Recent Dividend | N/A | 2.500 on 04/03/07 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.33 | 0.00 | ||